Pfizer brings 12 presentations to BPI 2026 in Boston. Its program concentrates on intensified upstream operations and CHO cell engineering. Work covers N-1 perfusion paired with intensified fed-batch processing, Raman-enabled automated lactate control, metabolic engineering toward cysteine prototrophy, and cutting buffer consumption in platform chromatography.
| Organization | BPI 2026 Attendance |
|---|---|
Pfizer New York, New York | 1 Senior Scientist · 1 Scientist, Purification Process Development · 1 Postdoctoral Fellow, Upstream Processing · 1 Bioprocessing Expert · 7 other speakers |
Global pharmaceutical company developing and manufacturing medicines, vaccines and biologics, with in-house bioprocess research and development. | Talk Tue Sep 22 11:00am–11:30am Talk Wed Sep 23 11:15am–11:45am Talk Wed Sep 23 12:15pm–12:45pm Chair Thu Sep 24 11:25am–11:30am Talk Thu Sep 24 11:30am–12:00pm Chair Thu Sep 24 2:10pm–2:15pm Chair Thu Sep 24 2:10pm–2:15pm Talk Thu Sep 24 2:45pm–3:15pm Talk Fri Sep 25 9:00am–10:00am Keynote Fri Sep 25 9:30am–10:00am Panel Fri Sep 25 10:40am–11:20am PANEL: What is AI Ready Data? Digital Biomanufacturing & AI Panel Fri Sep 25 2:30pm–3:30pm |
Instantly find 20 buyers from Pfizer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction